Coronavirus is a family of viruses that can live and reproduce in mammals and birds. In humans, they can cause mild to severe diseases in the respiratory system. There are no vaccines or anti-viral drugs currently available to prevent or treat coronavirus infections.
Coronaviruses are RNA viruses with a positive sense single-stranded RNA genome. When the infectious agent is looked at under a microscope, the outer part of the viral particle is reminiscent of the solar corona or crown that appears around the sun. This comes from the club-shaped proteins that cover the virion’s capsid.
These viruses were discovered in the late 1960s in the infected bronchioles of chickens and in humans that were exhibiting symptoms similar to the common cold. Other members of this virus family include: SARS-CoV which emerged in 2003, HCoV NL63 in 2004, HKU1 in 2005, MERS-CoV in 2012, and most recently, SARS-CoV-2 in 2019.
Tools to Support Your COVID-19 Research
Enzo and its Online Market Place Axxora Provide a Wide Range of COVID-19 Solutions
With the infection rate and mortality rate rising every day, this novel infection is currently a global health risk concerning us all. This virus, officially named COVID-19 by the World Health Organization, is transmittable from person to person and has continued to spread across the globe since its initial outbreak in January 2020. It is the seventh virus in the coronavirus family to affect humans, different from the MERS-CoV and SARS-CoV viruses. To aid the efforts of developing vaccines and neutralizing antibodies against it, we provide a high-quality portfolio of respiratory antibodies, antigens, and detection kits to help you accelerate your research and help combat this global concern.
COVID-19 Detection
COVID-19 RT-qPCR Assay Solutions COVID-19 and Coronavirus-Related Proteins Products Related To ELISA Assay Development
COVID-19 Characterization
Coronavirus Antibodies COVID-19 and Coronavirus Related Proteins Products Related to Coronavirus Biology
COVID-19 Therapeutic Development
COVID-19 and Coronavirus Related Proteins Coronavirus Antibodies Drug Discovery Small Molecules Therapeutics Antiviral Response Inflammation and Immune Response Monitoring MAPK Signaling Pathway Monitoring Scale up Production
We, the management and staff of P. ZAFIROPOULOS S.A. carefully monitor the worldwide implications of the endemic, and assess the difficulties that were brought about in our lives by SARS-CoV-2 new virus. In this context we would like to assure you that we are taking all necessary steps to ensure business continuity and active involvement in the “fight against COVID-19” while minimizing the risk for all our employees.
We hereby confirm that, given the critical mission of P. ZAFIROPOULOS S.A. in assisting our customers, the healthcare professionals, in the Public and Private Health Care sectors in Greece, we continue our operation, with a sense of responsibility and perseverance, without production or distribution disruptions, while taking all necessary precautions to protect our employees and customers.
Management and staff of P. ZAFIROPOULOS S.A. are available, as usual, via phone or email for any questions you might have. Our technical, scientific and administration teams are ready to assist you through:
The management and staff at P. ZAFIROPOULOS S.A. would like to express our gratitude and appreciation, and offer our support particularly to all healthcare professionals for their valuable contribution in the context of this global health crisis.
AIGS is the fully integrated system for fast molecular diagnostics, which combines the nucleic acids extraction and realtime PCR amplification, by using the microfluidic cartridge preassembled kit to realize the fully integrated gene data analysis for the samples. It can be widely used for many kinds of gene detection, such as the clinical diagnostic market, food safety, agriculture, army and public security
As the new generation gene detection system, AIGS realizes the fully integrated detection from sampling into the report. It is portable and can run each sample at any time and automatically transfer the data as your wish. It is a close system with no contamination and can be easily operated by the user. No need extra nucleic acid purification machine or PCR lab, by using the preassembled kits, AIGS can run as a POCT system without the complicated operation.
A full automatic system
Sample extraction
Nucleic acid purification
Nucleic acid amplification
Data analysis
Report
Each sample is individually controlled by AIGS.
Intuitive & easy operating interfaces
Features:
Electromagnetic micro array control magnetic beads moving, mixing, washing, etc.
NGeneBio covers cancer in vitro diagnosis and companion diagnosis, bioinformatics system business, disease diagnosis, liquid biopsy We would like to contribute to the opening of the era of precision medicine through diagnostic products and services that have proven their safety and effectiveness.
ImuPro is a concept that combines a sophisticated and reliable blood analysis for IgG food allergies with our unique post-test guidance. Up to 270 foods are tested. Together with your test results you will receive your individual nutritional concept – your building blocks to a healthier life.
Your trusted companion on your path to better health
Your test results and your personal nutritional guidelines will help you find to the foods that are good for you and to pinpoint your individual “trigger foods”. By avoiding the foods that cause you problems, inflammatory processes can be reduced or even stopped and your body can recover.
Are you suffering from the following symptoms?
Stomach-ache, bloating, diarrhoea, constipation, nausea: Could a delayed IgG food allergy be responsible for chronic gastrointestinal complaints of unclear origin?
Headaches and migraine are still unclear. A large number of people suspect that foods may play a role. Could an IgG food allergy trigger attacks?
Mechanisms of excess weight are not completely understood yet. Low-grade inflammatory processes could have an impact on obesity. Could an IgG food allergy promote them?
Choose the ImuPro test that is the most appropriate for you: The options range from a purely diagnostic test to a comprehensive solution with personalised nutritional guidance and recipes tailored to your personal needs.
ImuPro Screen⁺ – the stepping stone : ImuPro Screen⁺ provides an individual analysis of 44 very common foods, such as dairy, cereals and chicken egg. It is a purely diagnostic examination. You will receive a brief report containing individual results for all the tested foods at a glance.
ImuPro Basic – the trusted guide: ImuPro Basic tests the 90 most important foods, such as typical kinds of meat, vegetables, fruits, cereals, dairy products and chicken egg. You will receive a comprehensive report and personal nutritional guidelines.
ImuPro Complete – the comprehensive companion: ImuPro Complete tests 270 foods and additives. It analyses the typical kinds of meat, vegetables, fruits, cereals, dairy products and egg. Their alternatives are also tested, plus region-specific foods, a huge number of spices, tea, coffee, wine, thickening agents and preservatives.
You will receive a comprehensive report, personal nutritional guidelines and recipes specifically tailored to your personal needs.
ImuPro Vegetarian – The green guide: ImuPro Vegetarian tests the 90 most important foods, such as typical kinds of vegetables, fruits, cereals, dairy products and chicken egg. You will receive a comprehensive report and personal nutritional guidelines.
A breakthrough in the early detection of HPV16-induced oropharyngeal cancer.
Do you want to detect cancer in the oral cavity and oropharyngeal area of your patients at an earlier stage by means of an easy-to-use test?
More and more patients develop HPV16-positive cancer. These tumours are generally detected quite late. However, they respond to therapy much better than HPV-negative tumors. The new better and practicable method for the early detection of oral and oropharyngeal cancer.
Better treatment success thanks to earlier detection.
Often early-stage oropharyngeal cancer is not yet visible and still asymptomatic. Yet, treatment outcomes for early-stage tumours are significantly better than for tumours detected in later stage. If such tumours are HPV16-induced, then antibodies can circulate in the very early stage. These antibodies are DRH1 antibody equivalents and can be detected with Prevo-Check® using a highly specific monoclonal antibody called “anti-HPV16 L1 DRH1”. Early detection can improve your patient’s prognosis. Including Prevo-Check® in your medical services can significantly increase survival compared to that associated with later initial diagnosis.
Easy to use and fast results.
If cancer in the oral cavity and oropharyngeal area is induced by HPV, in particular by HPV16, then it is very likely to be located in the oropharynx. A careful inspection of this area is time-consuming and lesions can be missed. Prevo-Check® offers additional meaningful support. It only requires 1 drop of capillary blood or alternatively 25μL of serum. Prevo-Check® provides results within 20 minutes, which is decisive for the subsequent steps.
Results with high specificity
Due to its extremely high specificity of 99,5% (or greater), a positive Prevo-Check® result indicates the presence of an HPV16-induced malign cell growth. This means that clinically relevant follow-up examinations can be actioned immediately. The highly specific antibody clone DRH1 and the capability for early detection of pre-cancer stages implies meaningful time-savings, earlier treatment options with better out-comes and herewith a better prognosis for your patients. Abviris supplies documentation and further tools that can be used to raise awareness of this important test and to display this special diagnostic service in the doctor’s office.
6th Congress of the Hellenic Society of Gene Therapy and Regenerative Medicine, May 26-28, 2023, Cotsen Hall, American School of Classical Studies, Athens.
5th International Conference on ImmunoMetabolism: Molecular and Cellular Immunology of Metabolism, May 21-26, 2023, Avra Imperial Hotel & Conference Center, Chania Crete.
21st SIS World Congress on Breast Cancer and Breast Healthcare. May 3-6, 2023, Rhodes Island – Greece. International Conference Center -RODOS PALACE Hotel.
Development of Innovative Diagnostic Tools for Detection and Characterization of Circulating Cancer Cells in Patient’s Blood (JUNBlood), March 17, Conference Center, University of Patras
9th Hellenic Conference of the Hellenic Society of Medical Mycology “Fungal infections: diagnostic and therapeutic challenges”, 19-21st of November 2021, Divani Palace Acropolis Hotel
70th Panhellenic Conference of the Hellenic Society of Biochemistry and Molecular Biology, 29th November – 1st December 2019, Eugenides Foundation, Athens
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
